By Christiana Sciaudone
Investing.com -- Goodrx Holdings Inc (NASDAQ:GDRX) fell 6.6% on Thursday after reporting a surprise loss for the quarter in its first earnings release as a public company.
The tele-medicine and digital prescription platform, which went public in September, posted an adjusted loss per share of 21 cents on $140.5 million in revenue. Analysts were calling for earnings of 9 cents a share.
GoodRx cited an increase in stock-based compensation related to the company's IPO for the loss.
The fourth quarter and full-year forecasts were better. The company said it expects about $148 million in the current period and about $545 million for the year, both of which topped consensus.
GoodRx also said its monthly active users rebounded after dipping in the previous quarter. The company had 4.9 million MAUs, topping both the second quarter's 4.4 million and the 3.8 million from a year earlier.